From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Dec 18, 2003
MDL Docket No. 1290, Misc. No. 99ms276 (D.D.C. Dec. 18, 2003)

Opinion

MDL Docket No. 1290, Misc. No. 99ms276

December 18, 2003


ORDER


For the reasons stated from the bench at the hearing on December 18, 2003, it is hereby ORDERED that status hearings shall occur on the following dates:

— Monday, January 12, 2004 at 10:00 a.m.;

— Wednesday, February 04, 2004 at 10:00 a.m.;

— Wednesday, March 24, 2004 at 10:00 a.m.;

— Wednesday, May 05, 2004 at 10:00 a.m.; and

— Wednesday, June 23, 2004 at 10:00 a.m. It is further
ORDERED that a Joint Proposed Agenda for each status hearing shall be filed with the Court no later than 12:00 p.m. three business days prior to each hearing.

SO ORDERED.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Dec 18, 2003
MDL Docket No. 1290, Misc. No. 99ms276 (D.D.C. Dec. 18, 2003)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION, This Order applies to…

Court:United States District Court, D. Columbia

Date published: Dec 18, 2003

Citations

MDL Docket No. 1290, Misc. No. 99ms276 (D.D.C. Dec. 18, 2003)